Literature DB >> 8139572

Modulating the potency of an activator in a yeast in vitro transcription system.

Y Ohashi1, J M Brickman, E Furman, B Middleton, M Carey.   

Abstract

The intrinsic stimulatory potential or potency of a eukaryotic gene activator is controlled by the interaction between the activation domain and the transcriptional machinery. To further understand this interaction, we undertook a biochemical study to identify parameters that could be used to modulate activator potency. We considered how varying the number of activation domains, their flexibility, and the number of promoter sites affects potency in a yeast nuclear extract. The effects of GAL4 derivatives bearing either one, two, or four herpes simplex virus VP16 activation domains (amino acids 413 to 454) were measured on DNA templates containing one or two GAL4 sites in a Saccharomyces cerevisiae nuclear extract. We found that multimerized VP16 activation domains acted synergistically to increase the potency of the activators. The spacing between the activation domains was critical, such that the increased flexibility imparted by a protein linker contributed to increased activator potency. With highly potent activators, the levels of transcription stimulated on a single site were saturating, whereas the stimulatory effect of weaker activators increased with the number of sites. We discuss how these biochemical studies relate to the mechanism of gene activation and synergy in a yeast in vitro system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139572      PMCID: PMC358639          DOI: 10.1128/mcb.14.4.2731-2739.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.

Authors:  M Carey; J Kolman; D A Katz; L Gradoville; L Barberis; G Miller
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 2.  Advances in RNA polymerase II transcription.

Authors:  L Zawel; D Reinberg
Journal:  Curr Opin Cell Biol       Date:  1992-06       Impact factor: 8.382

3.  Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements.

Authors:  S Y Tsai; M J Tsai; B W O'Malley
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

4.  Multiple and cooperative trans-activation domains of the human glucocorticoid receptor.

Authors:  S M Hollenberg; R M Evans
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

Review 5.  Synergism in transcriptional activation: a kinetic view.

Authors:  D Herschlag; F B Johnson
Journal:  Genes Dev       Date:  1993-02       Impact factor: 11.361

6.  Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator.

Authors:  J L Regier; F Shen; S J Triezenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Many transcription factors interact synergistically with steroid receptors.

Authors:  R Schüle; M Muller; C Kaltschmidt; R Renkawitz
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

8.  New eukaryotic transcriptional repressors.

Authors:  S Saha; J M Brickman; N Lehming; M Ptashne
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

9.  Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions.

Authors:  K Seipel; O Georgiev; W Schaffner
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  A synergistic increase in potency of a multimerized VP16 transcriptional activation domain.

Authors:  K H Emami; M Carey
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  22 in total

1.  A general strategy to enhance the potency of chimeric transcriptional activators.

Authors:  S Natesan; E Molinari; V M Rivera; R J Rickles; M Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  TFIIB-facilitated recruitment of preinitiation complexes by a TAF-independent mechanism.

Authors:  Roderick T Hori; Shuping Xu; Xianyuan Hu; Sung Pyo
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

3.  Quantitation of putative activator-target affinities predicts transcriptional activating potentials.

Authors:  Y Wu; R J Reece; M Ptashne
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

4.  Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains.

Authors:  X Luo; M Sawadogo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  The activation domain of the maize transcription factor Opaque-2 resides in a single acidic region.

Authors:  D Schmitz; S Lohmer; F Salamini; R D Thompson
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

6.  An artificial transcriptional activating region with unusual properties.

Authors:  X Lu; A Z Ansari; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

7.  Modulation of transcription factor function by an amino acid: activation of Put3p by proline.

Authors:  Christopher A Sellick; Richard J Reece
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers.

Authors:  B R Graveley; K J Hertel; T Maniatis
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Modeling Pseudomonas aeruginosa pathogenesis in plant hosts.

Authors:  Melissa Starkey; Laurence G Rahme
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy.

Authors:  Sunetra Ray; Ramasamy Paulmurugan; Manish R Patel; Byeong C Ahn; Lily Wu; Michael Carey; Sanjiv S Gambhir
Journal:  Mol Ther       Date:  2008-09-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.